Sterile injectable solution
Therapeutically classification: Antibiotic
Composition: Each ml contains:
Target species: Horses, Cattle, Sheep, Dogs and Cats
Baymetozin® 24% is indicated in the treatment of respiratory tract infections with bacterial origin including rhinitis, pneumonia and bronchitis and in secondary bacterial infections due to viral or mycoplasma infections. It is also indicated in urogenital tract infections such as nephritis, cystitis, urethritis, metritis and vaginitis and alimentary tract infections like neonatal diarrhea and salmonellosis. Other infections include foot rot, acute mastitis, and infections of eye, ear and mouth. Baymetozin® has an excellent efficacy in anti-microbial resistance conditions, septicemia, postoperative and postpartum infections.
Mechanism of action:
Baymetozin® 24% is a potentiated sulfonamide preparation. This product has a sulfonamide in combination with trimethoprim that produce a double blockade in folic acid synthesis and prevent bacterial thymidine synthesis and is a bactericide. The efficacy of this product is greater than when each component is used alone. The bactericidal spectrum includes both gram-negative and gram-positive bacteria including Streptococcus spp., Staphylococcus spp., Pneumococcus spp., Enterococcus spp., Actinobacillus spp., Actinomyces spp., Salmonella spp., Pasteurella spp., Proteus spp., E. coli, Corynebacterium spp., Clostridium spp., Vibrio spp., Bordetella spp., Brucella spp., Klebsiella spp., Shigella spp. and Haemophilus spp.
Dosage and Administration:
Cattle and sheep: 15 mg/kg B.W. (1 ml/16 kg B.W.) by IM or slow IV administration.
Horses: 15 mg/kg B.W. (1 ml/16 kg B.W.), by slow IV administration.
Dogs and cats: 30 mg/kg B.W. (1 ml/8 kg B.W.), by SC injection.
A single injection may be sufficient in uncomplicated conditions, but in severe infections the administration should be repeated up to 5 consecutive days or 2 doses after the clinical signs of infection are resolved.
Meat: 10 days after the last treatment
Milk: 3 days after the last treatment
Should not be administered intraperitoneally, intra-arterially or intrathecally.
Do not use in animals with known sulfonamide sensitivity, severe liver and kidney impairment and blood dyscrasias.
Do not administer to horses exhibiting drug-induced cardiac arrhythmias subsequent to taking medications like anesthetics and sedatives.
Adequate drinking water should be available to the animal during the treatment period.
The recommended site in dogs is the loose skin at the top of the neck.
Keep out of reach and sight of children.
Use only under the prescription of a veterinarian.
In use stability:
28 days after first needle insertion
Do not store above 25°C, keep away from light and freezing.
50 ml vial in a box
For veterinary use only